Topical cidofovir (HPMPC) is an effective adjuvant to surgical treatment of anogenital condylomata acuminata

Diseases of the Colon and Rectum

Volumn 46, Issue 8, 2003, Pages 1103-1109

  Coremans, G ^a,b   Margaritis, V ^a   Snoeck, R ^c   Wyndaele, J ^a   De Clercq, E ^c   Geboes, K ^b   Abcarian, Herand ^a  

^a Department of Gastroenterology ^*

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Anogenital condylomata acuminata; Antiviral treatment; Cidofovir; Coagulation; Smoking

Indexed keywords

ANALGESIC AGENT; CIDOFOVIR;

ADJUVANT CHEMOTHERAPY; ADULT; ANALGESIA; ANTIVIRAL ACTIVITY; ANUS DISEASE; ANUS TUMOR; ARTICLE; BLEEDING; CARCINOMA IN SITU; CLINICAL ARTICLE; CONDYLOMA ACUMINATUM; CONSTIPATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; ELECTROCOAGULATION; EROSION; FEMALE; FEVER; GENITAL TRACT INFECTION; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; MALE; PAIN; PAIN ASSESSMENT; PENIS; RECURRENCE RISK; RELAPSE; REMISSION; SKIN INJURY; SMOKING; STATISTICAL SIGNIFICANCE; TISSUE DISTRIBUTION; ULCER HEALING; UTERINE CERVIX; VULVA; WART VIRUS;

ADMINISTRATION, TOPICAL; ADULT; ANTIVIRAL AGENTS; ANUS DISEASES; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; CONDYLOMATA ACUMINATA; CYTOSINE; ELECTROCOAGULATION; FEMALE; GENITAL DISEASES, FEMALE; GENITAL DISEASES, MALE; HUMANS; MALE; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS;

EID: 0042529039     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-004-7287-5     Document Type: Article

References (23)

1. Van Ranst M, Kaplan JB, Burk RD. Phylogenetic classification of human papilloma viruses: correlation with clinical manifestations. J Gen Virol 1992;73:2653-60.
2. Ling MR. Therapy of genital human papillomavirus infections. Part I: indications for and justification of therapy. Int J Dermatol 1992;31:682-6.
3. Frisch M, Glimelius B, van den Brule AJ, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997;337:1350-8.
4. Haefner HK, Tate JE, McLachlin CM, Crum CP. Vulvar intraepithelial neoplasia: age, morphological phenotype, papillomavirus DNA, and coexisting invasive carcinoma. Hum Pathol 1995;26:147-54.
5. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-8.
6. Aynaud O, Ionesco M, Barrasso R. Penile intraepithelial neoplasia. Specific clinical features correlate with histologic and virologic findings. Cancer 1994;74:1762-7.
7. Nuovo G, Hochman H, Eliezri Y, et al. Detection of human papillomavirus DNA in penile lesions histologically negative for condylomata. Am J Surg Pathol 1990;14:829-36.
8. Schneider A, Kirchmayr R, de Villiers E, Gissmann L. Subclinical human papillomavirus infections in male sexual partners of female carriers. J Urol 1988;140:1431-4.
9. Baker GE, Tyring SK. Therapeutic approaches to papilloma virus infections. Dermatol Clin 1997;15:331-40.
10. Ferenczy A, Mitao M, Negai N, Silverstein SJ, Crum CP. Latent papillomavirus and recurring genital warts. N Engl J Med 1985;313:784-8.
11. Perry CM, Lamb HM. Topical imiquimod: a review of its use in genital warts. Drugs 1999;58:375-90.
12. Welander CE, Homesley HD, Smiles KA, Peets EA. Intralesional interferon alpha-2b for the treatment of genital warts. Am J Obstet Gynecol 1990;162:348-54.
13. De Clercq E. Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections. Intervirology 1997;40:295-303.
14. Snoeck R, Van Ranst M, Andrei G, et al. Treatment of anogenital papillomavirus infections with an acyclic nucleoside phosphonate analogue. N Engl J Med 1995;333:943-4.
15. Snoeck R, Andrei G, De Clercq E. Cidofovir in the treatment of HPV-associated lesions. Verh K Acad Geneeskd Belg 2001;63:93-122.
16. Snoeck R, Wellens W, Desloovere C, et al. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2 phosphonylmethoxypropyl) cytosine]. J Med Virol 1998;54:219-25.
17. Van Cutsem E, Snoeck R, Van Ranst M, et al. Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine. J Med Virol 1995;45:230-5.
18. Handsfield HH. Clinical presentation and natural course of anogenital warts. Am J Med 1997;102:16-20.
19. Feldman JG, Chirgwin K, Dehovitz JA, Minkoff H. The association of smoking and risk of condyloma acuminatum in women. Obstet Gynecol 1997;89:346-50.
20. Petry KU, Kochel H, Bode U, et al. Human papillomavirus is associated with the frequent detection of warty and basaloid high grade neoplasia of the vulva and cervical neoplasia among immunocompromised women. Gynecol Oncol 1996;60:30-4.
21. Arany I, Muldrow M, Tyring SK. Correlation between mRNA levels of IL-6 and TNF alpha and progression rate in anal squamous epithelial lesions from HIV-positive men. Anticancer Res 2001;21:425-8.
22. Aynaud O, Piron D, Bijaoui G, Casanova JM. Developmental factors of urethral human papillomavirus lesions: correlation with circumcision. BJU Int 1999;84:57-60.
23. III). J Med Virol 2000;60:205-9.